Phase 2a dose escalation trial of Mipsagargin in East Asian patients with Hepatocellular Carcinoma

Trial Profile

Phase 2a dose escalation trial of Mipsagargin in East Asian patients with Hepatocellular Carcinoma

Planning
Phase of Trial: Phase II

Latest Information Update: 06 Jan 2016

At a glance

  • Drugs Mipsagargin (Primary)
  • Indications Liver cancer
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Inspyr Therapeutics
  • Most Recent Events

    • 20 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top